Study of Management of Pasireotide-induced Hyperglycemia in Adult Patients With Cushing's Disease or Acromegaly

NCT02060383 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

249

Enrollment

INDUSTRY

Sponsor class

Conditions

Cushing's Disease
Acromegaly

Interventions

DRUG: Pasireotide s.c.
DRUG: Sitagliptin
DRUG: Liraglutide
DRUG: Insulin
DRUG: Pasireotide LAR
DRUG: Metformin

Sponsor

Novartis Pharmaceuticals